Product containing polymyxin B and trimethoprim (medicinal product)
RxNorm 219314
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 219314 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Product containing polymyxin B and trimethoprim (medicinal product).
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
MINPrescribable
Multiple Ingredients (MIN):
Polymyxin B / trimethoprim
(Atom ID: 12352311)
PTPrescribable
Designated preferred name (PT):
Polymyxin B- and trimethoprim-containing product
(Atom ID: 10809394)
FNPrescribable
Full form of descriptor (FN):
Product containing polymyxin B and trimethoprim (medicinal product)
(Atom ID: 9731291)
Patient Education
Polymyxin B and Trimethoprim Ophthalmic
Polymyxin B and trimethoprim ophthalmic combination is used to treat bacterial infections of the eye including conjunctivitis (pinkeye; infection of the membrane that covers the outside of the eyeball and the inside of the eyelid) or blepharoconjunctivitis (infection of the membrane that covers the outside of the eyeball and the inside and outer parts of the eyelid). Polymyxin B and trimethoprim are in a class of medications called antibiotics. They work by killing bacteria that cause infections.
[Learn More]
* Please review the disclaimer below.